BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1715838)

  • 1. Characteristic behavior of serum elastase 1 in pancreatic cancer.
    Kimura T; Ito T; Sumii T; Muranaka T
    Fukuoka Igaku Zasshi; 1991 Jun; 82(6):355-61. PubMed ID: 1715838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early detection of pancreatic cancer by serum markers].
    Nakae Y; Naruse S; Shibata T; Kitagawa M; Kondo T; Hayakawa T; Kuno N; Kurimoto K
    Rinsho Byori; 1994 Feb; 42(2):139-42. PubMed ID: 7511183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum immunoreactive elastase: is it useful for the diagnosis of pancreatic cancer?
    Gullo L; Pezzilli R; Ventrucci M; Lesi C; Zoni L; D'Ambrosi A; Alvisi V
    Pancreas; 1989; 4(3):335-8. PubMed ID: 2734276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases.
    Satake K; Kanazawa G; Kho I; Chung Y; Umeyama K
    Am J Gastroenterol; 1985 Aug; 80(8):630-6. PubMed ID: 2411125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum pancreatic enzymes in the diagnosis of carcinoma of the pancreas].
    Pezzilli R; Ventrucci M; Talarico R; Naldoni P; Cassano A; Gullo L
    G Ital Oncol; 1989; 9(1):7-13. PubMed ID: 2468605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitive serum markers for detecting pancreatic cancer.
    Hayakawa T; Kondo T; Shibata T; Hamano H; Kitagawa M; Sakai Y; Ono H
    Cancer; 1988 May; 61(9):1827-31. PubMed ID: 2451556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the role of serum elastase 1 in the diagnosis of pancreatic cancer.
    Wu D; Qian JM; Deng RX; Jiang WJ; Chen YJ; Liu XH; Lu XH
    Chin J Dig Dis; 2006; 7(2):117-20. PubMed ID: 16643340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum elastase 1 appears specific for cancer of the pancreatic head.
    Ito T; Kimura T; Nawata H
    Am J Gastroenterol; 1991 Dec; 86(12):1778-83. PubMed ID: 1962622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of serum CA 19-9 determination in the diagnosis of pancreatic carcinoma].
    Pei DP
    Zhonghua Wai Ke Za Zhi; 1990 Oct; 28(10):625-7, 638-9. PubMed ID: 2086060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum pancreatic enzymes and enzyme inhibitor as a tumor marker for pancreatic cancer].
    Ogawa M
    Rinsho Byori; 1986 Nov; 34(11):1229-35. PubMed ID: 2434691
    [No Abstract]   [Full Text] [Related]  

  • 11. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Developing a hospital-based high risk scoring model and screening strategy for pancreatic cancer].
    Deng RX; Lu XH; Wang L; Li H; Qian JM; Yang AM; Zhong SX; Guo XZ; Zhou L; Wu X; Yang XO; Jiang WJ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2038-42. PubMed ID: 16313796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer.
    Ghazale A; Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Clain JE; Pearson RK; Pelaez-Luna M; Petersen BT; Vege SS; Farnell MB
    Am J Gastroenterol; 2007 Aug; 102(8):1646-53. PubMed ID: 17555461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in serum levels of pancreatic isoamylase, lipase, trypsin, and elastase 1 after endoscopic retrograde pancreatography.
    Okuno M; Himeno S; Kurokawa M; Shinomura Y; Kuroshima T; Kanayama S; Tsuji K; Higashimoto Y; Tarui S
    Hepatogastroenterology; 1985 Apr; 32(2):87-90. PubMed ID: 3847383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined detection of serum tumor markers for differential diagnosis of solid lesions located at the pancreatic head.
    Liao Q; Zhao YP; Yang YC; Li LJ; Long X; Han SM
    Hepatobiliary Pancreat Dis Int; 2007 Dec; 6(6):641-5. PubMed ID: 18086633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CA 19-9 in serum and pancreatic juice: its role in the differential diagnosis of resectable pancreatic cancer from chronic pancreatitis.
    Malesci A; Evangelista A; Mariani A; Bersani M; Bonato C; Basilico M; Montorsi M; Beretta E
    Int J Pancreatol; 1988; 3 Suppl 1():S119-23. PubMed ID: 3209865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pancreatic elastase 1].
    Ogawa M
    Rinsho Byori; 2001 Nov; Suppl 116():131-4. PubMed ID: 11797373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor markers for pancreatic and biliary tract cancer].
    Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of elastase-1 serum levels in post ERCP/EST pancreatic damage.
    Hardt PD; Fadgyas T; Kress O; Doppl WE; Weber HP; Bimler EA; Temme H; Klör HU
    Z Gastroenterol; 1999 Aug; 37(8):701-5. PubMed ID: 10494604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The diagnostic significance of carbohydrate antigen 19-9 in pancreatic carcinomas].
    Chen YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Jun; 11(3):229-31. PubMed ID: 2529993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.